Medscape Hematology-Oncology Headlines This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Q & A: Immunotherapy in Renal Cell Carcinoma (RCC) Q & A: Immunotherapy in Renal Cell Carcinoma (RCC)
A collaboration and conversation between Medscape and Dr Karl D ' Silva on the impact of immunotherapy in renal cell carcinoma.Medscape (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 8, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Zanubrutinib Label Expands to Include RR Follicular Lymphoma Zanubrutinib Label Expands to Include RR Follicular Lymphoma
The Bruton ' s kinase inhibitors new follicular lymphoma indication is for combination use with obinutuzumab.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 8, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Does Exercise Reduce Cancer Risk? It's Just Not That Simple Does Exercise Reduce Cancer Risk? It's Just Not That Simple
Although guidelines tout the benefits of exercise for lowering cancer risk, the research on exercise and cancer risk paints a much more complex picture.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 8, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Trastuzumab Deruxtecan: Effects in Multiple Cancer Types Trastuzumab Deruxtecan: Effects in Multiple Cancer Types
Dr Maurie Markman discusses the concept of focusing on a particular molecular target and then potentially looking at the value of that drug across multiple tumor types.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 7, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

GSK's Blood Cancer Drug Meets Main Goal in Late-stage Trial; Analysts Tout Comeback GSK's Blood Cancer Drug Meets Main Goal in Late-stage Trial; Analysts Tout Comeback
GSK said on Thursday a study showed its experimental drug Blenrep helped extend survival in patients with a type of blood cancer without symptoms worsening, marking a...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 7, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

FDA Okays Pfizer Antibody-Drug Conjugate for Pediatric ALL FDA Okays Pfizer Antibody-Drug Conjugate for Pediatric ALL
A complete remission rate of 42% led to the approval of inotuzumab ozogamicin for children.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 7, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Change Healthcare Cyberattack:'Unsustainable' for Oncology Change Healthcare Cyberattack:'Unsustainable' for Oncology
Change Healthcare is focused on restoring its systems and minimizing disruptions to oncology practices after a cyberattack that occurred over 2 weeks ago.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 6, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Is Primary Tumor Resection Beneficial in Stage IV CRC? Is Primary Tumor Resection Beneficial in Stage IV CRC?
Primary tumor resection before chemotherapy does not prolong survival in patients with CRC and unresectable metastases, combined results from two trials indicate.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 6, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Cancer-causing Chemical Found in Clinique, Clearasil Acne Treatments, U.S. Lab Reports Cancer-causing Chemical Found in Clinique, Clearasil Acne Treatments, U.S. Lab Reports
High levels of cancer-causing chemical benzene were detected in some acne treatments from brands including Estee Lauder ' s Clinique, Target ' s Up& Up and Reckitt...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 6, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Latest J & J Talc Trial Ends With Hung Jury Latest J & J Talc Trial Ends With Hung Jury
The latest trial over claims that Johnson& Johnson ' s talc products cause cancer ended in a mistrial on Tuesday, as a Florida state court jury said it could not agree on...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Community: Key to Keeping Up-to-Date in Thoracic Oncology Community: Key to Keeping Up-to-Date in Thoracic Oncology
Dr Mark Kris discusses the importance of community in keeping up-to-date with the latest news and data in thoracic cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Can Changes to Chemo Improve Tolerability in Older Patients? Can Changes to Chemo Improve Tolerability in Older Patients?
Reducing treatment doses and altering treatment schedules can help reduce adverse events and improve tolerability in older patients with advanced cancer, a new study suggested.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

' Less Is More' in Myeloma'Less Is More' in Myeloma
Dr. Mohyuddin discusses " less is more " clinical trials that challenge conventional practices and have shown improved outcomes with lower drug dosages.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Oophorectomy Saves Lives in Women With BRCA1/2 Mutations Oophorectomy Saves Lives in Women With BRCA1/2 Mutations
In women with BRCA1/2 pathogenic variants, preventive bilateral oophorectomy was associated with a 68% lower risk for death from any cause, a large cohort study found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

PATHFINDER: Not Quite Hitting the Mark? PATHFINDER: Not Quite Hitting the Mark?
Dr Kathy Miller discusses the potential mismatch between results and conclusions from the PATHFINDER study.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 4, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news